AI-Powered Drug Discovery: CardiaTec Biosciences Secures £1.4M to Combat Cardiovascular Diseases
The CardiaTec Biosciences Cardiovascular diseases (CVDs) remain the leading global cause of death, despite decades of research. While oncology and neurodegenerative diseases have witnessed significant technological advancements, the field of CVDs has lagged behind. New technologies are urgently needed to address this gap and combat the persistent threat posed by heart diseases. A Systems Biology […]